Friday, July 10, 2026

Drug profile · INN

brigimadlin

brigimadlin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — brigimadlin
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

brigimadlin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN brigimadlin

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Brigimadlin Phase 3 · Boehringer Ingelheim · Liposarcoma, Dedifferentiated
  2. 1403-0001 Phase 1 · Boehringer Ingelheim · Advanced or metastatic solid tumors
  3. 1403-0002 Phase 1 · Boehringer Ingelheim · advanced solid tumors

Frequently asked questions

What is brigimadlin?

brigimadlin is an FDA-listed pharmaceutical active ingredient.